Antoine Gourmel

CHU Amiens Picardie
Amiens, FR 
Clinical Trials:Currently Recruiting for 1 Trial
CHU Amiens Picardie
Amiens, FR 

Overview

Antoine Gourmel practices practicing medicine in Amiens, France.

His clinical expertise encompasses Lymphangiomatosis, Hemangioma Thrombocytopenia Syndrome, Ganglioneuroblastoma, and Hemangioendothelioma.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

CHU Amiens Picardie
Amiens, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Device
Study Drugs: Melphalan or Melphalan + Topotecan, Etoposide, Carboplatin and Vincristine, Carboplatin, Intravitreal Melphalan Chemotherapy Injections
Study Phase: Phase 2/Phase 3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Etoposide, Vincristine, Carboplatin, Cyclophosphamide, Thiotepa
Study Phase: Phase 2
View 1 Less Clinical Trial

10 Total Publications

The impact of comparative genomic hybridization/single-nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia.
The impact of comparative genomic hybridization/single-nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: November 29, 2023

Frequently Asked Questions about Antoine Gourmel

Is Antoine Gourmel a top-rated expert for Lymphangiomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Antoine Gourmel is classified as an Experienced expert for Lymphangiomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antoine Gourmel participate in research or clinical trials?

Yes. Antoine Gourmel has published 10 articles and abstracts on conditions like Lymphangiomatosis. You can view a list of Antoine Gourmel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gourmel's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile